| HGNC Family | G protein-coupled receptors |
| Name | taste receptor, type 2, member 41 |
| Description | This gene encodes a member of the bitter taste receptor family which belong to the G protein-coupled receptor superfamily and are predominantly expressed in taste receptor cells of the tongue and palate epithelia. This intronless taste receptor gene encodes a seven-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered together with eight other taste receptor genes on chromosome 7. Chloramphenicol is an agonist for the encoded protein. [provided by RefSeq, Jul 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe collection of abstracts provided offers a broad view of the neuroendocrine mechanisms regulating energy balance, feeding behavior, and metabolic homeostasis. These studies detail how gut‐derived hormones such as ghrelin—as well as orexigenic neuropeptides including neuropeptide Y (NPY) and agouti‐related protein (AgRP)—modulate neuronal activity, mitochondrial function, and systemic metabolic responses through diverse intracellular pathways, receptor interactions, and neural circuitry. For example, several studies describe ghrelin’s activation of mitochondrial respiration and its dependence on UCP2 to stimulate feeding (e.g."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "and the essential roles of NPY and AgRP in mediating orexigenic responses (e.g.."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Additional works in the set probe the impact of these neuropeptides on stress‐induced metabolic adaptations, neurogenesis, sympathetic outflow, and even bone homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNotably, however, none of the abstracts reference or investigate TAS2R41. TAS2R41 belongs to the type 2 taste receptor family—a group classically implicated in bitter taste perception—and while it has been proposed to have modulatory roles beyond the gustatory system in other contexts, the current corpus of literature does not report any data on its expression, signaling functions, or influence on metabolic and neuroendocrine pathways. Thus, with respect to the provided studies, there is no available evidence to ascribe a functional role to TAS2R41.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, while the abstracts illuminate key mechanisms by which ghrelin, NPY, AgRP, and related intracellular systems integrate peripheral and central signals to control feeding, energy expenditure, stress responses, and even bone and immune functions"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "11"}, {"type": "fg_f", "ref": "2"}, {"type": "fg_fs", "start_ref": "12", "end_ref": "18"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "19"}, {"type": "fg_f", "ref": "1"}, {"type": "fg_fs", "start_ref": "21", "end_ref": "26"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_fs", "start_ref": "27", "end_ref": "31"}]}, {"type": "t", "text": "—there is no discussion of TAS2R41, leaving its potential roles in physiology to be explored in future studies.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Zane B Andrews, Zhong-Wu Liu, Nicholas Walllingford, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature07181"}], "href": "https://doi.org/10.1038/nature07181"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18668043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18668043"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H Y Chen, M E Trumbauer, A S Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2003-1596"}], "href": "https://doi.org/10.1210/en.2003-1596"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14962995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14962995"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kanji A Takahashi, Roger D Cone "}, {"type": "b", "children": [{"type": "t", "text": "Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2004-1397"}], "href": "https://doi.org/10.1210/en.2004-1397"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15591135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15591135"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Lydia E Kuo, Joanna B Kitlinska, Jason U Tilan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1611"}], "href": "https://doi.org/10.1038/nm1611"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17603492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17603492"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yan-Chuan Shi, Jackie Lau, Zhou Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2013.01.006"}], "href": "https://doi.org/10.1016/j.cmet.2013.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23395170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23395170"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "John C Igwe, Xi Jiang, Frane Paic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.22294"}], "href": "https://doi.org/10.1002/jcb.22294"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19670271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19670271"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "P D Raposinho, D D Pierroz, P Broqua, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0303-7207(01)00620-7"}], "href": "https://doi.org/10.1016/s0303-7207(01"}, {"type": "t", "text": "00620-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11738809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11738809"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hongqin Wang, Len H Storlien, Xu-Feng Huang "}, {"type": "b", "children": [{"type": "t", "text": "Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00230.2001"}], "href": "https://doi.org/10.1152/ajpendo.00230.2001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12006366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12006366"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Su Qian, Howard Chen, Drew Weingarth, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.22.14.5027-5035.2002"}], "href": "https://doi.org/10.1128/MCB.22.14.5027-5035.2002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12077332"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12077332"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "A Thorsell, M Heilig "}, {"type": "b", "children": [{"type": "t", "text": "Diverse functions of neuropeptide Y revealed using genetically modified animals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1054/npep.2002.0897"}], "href": "https://doi.org/10.1054/npep.2002.0897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12359508"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12359508"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shozo Jinno, Toshio Kosaka "}, {"type": "b", "children": [{"type": "t", "text": "Patterns of expression of neuropeptides in GABAergic nonprincipal neurons in the mouse hippocampus: Quantitative analysis with optical disector."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Comp Neurol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cne.10700"}], "href": "https://doi.org/10.1002/cne.10700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12746872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12746872"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Gavin A Bewick, James V Gardiner, Waljit S Dhillo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.04-3434fje"}], "href": "https://doi.org/10.1096/fj.04-3434fje"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16099943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16099943"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Blanca Ramos, David Baglietto-Vargas, Juan Carlos del Rio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2005.09.022"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2005.09.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16271420"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16271420"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shu Lin, Dana Boey, Nicola Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2005.11.006"}], "href": "https://doi.org/10.1016/j.npep.2005.11.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16439015"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16439015"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mallappa Anitha, Bindu Chandrasekharan, Joana R Salgado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2006.07.019"}], "href": "https://doi.org/10.1053/j.gastro.2006.07.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17030186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17030186"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xavier Fioramonti, Sylvain Contié, Zhentao Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db06-0567"}], "href": "https://doi.org/10.2337/db06-0567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17261674"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17261674"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Owain W Howell, Sharmalene Silva, Helen E Scharfman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2006.12.014"}], "href": "https://doi.org/10.1016/j.nbd.2006.12.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17317195"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17317195"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Katsuhiko Asanuma, Kirk Nicholas Campbell, Kwanghee Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0700917104"}], "href": "https://doi.org/10.1073/pnas.0700917104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17537921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17537921"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Suvi T Ruohonen, Ullamari Pesonen, Niko Moritz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db07-0722"}], "href": "https://doi.org/10.2337/db07-0722"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18276767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18276767"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Tim Karl, Liesl Duffy, Herbert Herzog "}, {"type": "b", "children": [{"type": "t", "text": "Behavioural profile of a new mouse model for NPY deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurosci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1460-9568.2008.06306.x"}], "href": "https://doi.org/10.1111/j.1460-9568.2008.06306.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18616565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18616565"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Bindu Chandrasekharan, Vanitha Bala, Vasantha L Kolachala, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0003304"}], "href": "https://doi.org/10.1371/journal.pone.0003304"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18836554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18836554"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Melissa J S Chee, Martin G Myers, Christopher J Price, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4031-09.2010"}], "href": "https://doi.org/10.1523/JNEUROSCI.4031-09.2010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20203197"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20203197"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Raquel Ferreira, Sara Xapelli, Tiago Santos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.164020"}], "href": "https://doi.org/10.1074/jbc.M110.164020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20959451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20959451"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Brian Solway, Soma C Bose, Gregory Corder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tonic inhibition of chronic pain by neuropeptide Y."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1017719108"}], "href": "https://doi.org/10.1073/pnas.1017719108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21482764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21482764"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Kristen R Vella, Preeti Ramadoss, Francis S Lam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2011.10.009"}], "href": "https://doi.org/10.1016/j.cmet.2011.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22100407"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22100407"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Tadashi Yoshida, Laura Semprun-Prieto, Richard D Wainford, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2011-1764"}], "href": "https://doi.org/10.1210/en.2011-1764"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22234465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22234465"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Scott B Baver, Kevin Hope, Shannon Guyot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leptin modulates the intrinsic excitability of AgRP/NPY neurons in the arcuate nucleus of the hypothalamus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4861-12.2014"}], "href": "https://doi.org/10.1523/JNEUROSCI.4861-12.2014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24741039"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24741039"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "José K van den Heuvel, Kara Furman, Myrtille C R Gumbs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y activity in the nucleus accumbens modulates feeding behavior and neuronal activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2014.06.008"}], "href": "https://doi.org/10.1016/j.biopsych.2014.06.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25109664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25109664"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Hana Uhlirova, Kıvılcım Kılıç, Peifang Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell type specificity of neurovascular coupling in cerebral cortex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.14315"}], "href": "https://doi.org/10.7554/eLife.14315"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27244241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27244241"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Ming-Dong Zhang, Swapnali Barde, Ting Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Orthopedic surgery modulates neuropeptides and BDNF expression at the spinal and hippocampal levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1614017113"}], "href": "https://doi.org/10.1073/pnas.1614017113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27791037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27791037"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Linda Engström Ruud, Mafalda M A Pereira, Alain J de Solis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NPY mediates the rapid feeding and glucose metabolism regulatory functions of AgRP neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-020-14291-3"}], "href": "https://doi.org/10.1038/s41467-020-14291-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31974377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31974377"}]}]}]}
|
| Synonyms | T2R41, T2R59 |
| Proteins | T2R41_HUMAN |
| NCBI Gene ID | 259287 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TAS2R41 has 1,547 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 61 datasets.
Click the + buttons to view associations for TAS2R41 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TAS2R41 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TAS2R41 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TAS2R41 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TAS2R41 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TAS2R41 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TAS2R41 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TAS2R41 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TAS2R41 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TAS2R41 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TAS2R41 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TAS2R41 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TAS2R41 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TAS2R41 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TAS2R41 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TAS2R41 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TAS2R41 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TAS2R41 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for TAS2R41 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TAS2R41 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TAS2R41 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TAS2R41 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TAS2R41 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TAS2R41 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TAS2R41 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TAS2R41 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TAS2R41 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TAS2R41 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TAS2R41 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TAS2R41 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TAS2R41 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TAS2R41 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TAS2R41 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TAS2R41 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TAS2R41 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TAS2R41 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TAS2R41 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TAS2R41 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TAS2R41 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TAS2R41 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TAS2R41 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TAS2R41 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TAS2R41 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TAS2R41 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving TAS2R41 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving TAS2R41 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TAS2R41 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TAS2R41 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TAS2R41 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TAS2R41 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TAS2R41 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TAS2R41 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving TAS2R41 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving TAS2R41 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TAS2R41 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TAS2R41 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TAS2R41 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TAS2R41 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TAS2R41 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TAS2R41 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TAS2R41 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TAS2R41 protein from the Wikipathways Pathways 2014 dataset. | |